Obesity hypoventilation syndrome

Overview

Obesity Hypoventilation Syndrome (OHS), also known as Pickwickian Syndrome, is a respiratory disorder primarily affecting individuals with significant obesity. It is characterized by inadequate ventilation in obese individuals, leading to low oxygen levels (hypoxemia) and elevated carbon dioxide (CO2) levels (hypercapnia) in the blood.

Pathophysiology

Mechanism

OHS results from a combination of factors related to obesity, including mechanical effects on the lungs and chest wall, decreased respiratory drive, and hormonal disturbances. The excess weight on the chest and abdomen hinders the normal expansion of the lungs and diaphragm, leading to hypoventilation.

Association with Sleep Disorders

OHS is closely associated with Obstructive Sleep Apnea (OSA) - a condition where excessive fat deposits around the upper airway cause intermittent obstruction during sleep. However, OHS can occur independently of OSA.

Clinical Features

Symptoms

• Daytime sleepiness
• Fatigue
• Shortness of breath
• Snoring
• Headaches (especially in the morning)

Complications

• Pulmonary hypertension
• Right heart failure (cor pulmonale)
• Secondary erythrocytosis

Diagnosis

Diagnosis involves a combination of clinical evaluation and tests such as:

• Polysomnography (sleep study)
• Arterial blood gas analysis
• Pulmonary function tests
• Echocardiogram

Treatment

Lifestyle Changes

• Weight loss
• Regular exercise
• Dietary modifications

Medical Management

• Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway Pressure (BiPAP) therapy
• Oxygen supplementation
• Medications to treat associated conditions

Prognosis

With appropriate treatment, the symptoms and complications of obesity hypoventilation syndrome can be managed effectively. Weight loss, in particular, has been shown to improve both respiratory function and overall health outcomes.

Epidemiology

The prevalence of obesity hypoventilation syndrome is increasing, paralleling the rise in obesity rates worldwide. OHS is more common in individuals with a body mass index (BMI) of 40 or higher and is often seen in conjunction with obstructive sleep apnea.

See also

• Obstructive sleep apnea
• Hypoventilation
• Sleep disorders
• Body Mass Index (BMI)
• Respiratory Failure
• Sleep Medicine

External links

• American Thoracic Society: Clinical Guideline on Obesity Hypoventilation Syndrome
• National Sleep Foundation: Obesity Hypoventilation Syndrome+
• World Health Organization
• American Lung Association

Summary

Obesity hypoventilation syndrome (OHS) is a condition in which severely overweight people fail to breathe rapidly or deeply enough, resulting in low oxygen levels and high blood carbon dioxide (CO2) levels. The syndrome is often associated with obstructive sleep apnea (OSA), which causes periods of absent or reduced breathing in sleep, resulting in many partial awakenings during the night and sleepiness during the day. The disease puts strain on the heart, which may lead to heart failure and leg swelling.

Obesity hypoventilation syndrome Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Transform Your Life with W8MD Weight Loss Centers

W8MD offers a physician-supervised weight loss program at various locations including New York, Pennsylvania and New Jersey. Our centers provide expert medical guidance, accept most insurances, and offer telemedicine options for convenience.

Why choose W8MD?

• Comprehensive care with FDA-approved medications including:
• Weight loss injections both generic and brand names:
  • Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
• Weight loss medications including Phentermine, Qsymia, Contrave, Diethylpropion etc.
• Accept most insurances for visits or discounted self pay cost.
• Generic weight loss injections starting from just $125.00 for the starting dose
• In person weight loss NYC and telemedicine medical weight loss options in New York city available

Book Your Appointment

Start your weight loss journey today at our centers in New York, New Jersey and Pennsylvania and visit W8MD.com Call (718)946-5500